Skip Nav Destination
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma
Issue Archive
May 24 2012
In this Issue
Table of Contents
Inside Blood
Blood Work
Perspectives
Review Article
Clinical Trials and Observations
Hematopoiesis and Stem Cells
Immunobiology
Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors
Patricia Ribeiro-dos-Santos,Emma L. Turnbull,Marta Monteiro,Agnès Legrand,Karen Conrod,Joshua Baalwa,Pierre Pellegrino,George M. Shaw,Ian Williams,Persephone Borrow,Benedita Rocha
Lymphoid Neoplasia
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
Clinical Trials & Observations
Shaji K. Kumar,Suzanne R. Hayman,Francis K. Buadi,Vivek Roy,Martha Q. Lacy,Morie A. Gertz,Jacob Allred,Kristina M. Laumann,Leif P. Bergsagel,David Dingli,Joseph R. Mikhael,Craig B. Reeder,A. Keith Stewart,Steven R. Zeldenrust,Philip R. Greipp,John A. Lust,Rafael Fonseca,Stephen J. Russell,S. Vincent Rajkumar,Angela Dispenzieri
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis
Javeed Iqbal,Yulei Shen,Yanyan Liu,Kai Fu,Elaine S. Jaffe,Cuiling Liu,Zhongfeng Liu,Cynthia M. Lachel,Karen Deffenbacher,Timothy C. Greiner,Julie M. Vose,Sharathkumar Bhagavathi,Louis M. Staudt,Lisa Rimsza,Andreas Rosenwald,German Ott,Jan Delabie,Elias Campo,Rita M. Braziel,James R. Cook,Raymond R. Tubbs,Randy D. Gascoyne,James O. Armitage,Dennis D. Weisenburger,Timothy W. McKeithan,Wing C. Chan
TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma
Brief Report
David W. Scott,Karen L. Mungall,Susana Ben-Neriah,Sanja Rogic,Ryan D. Morin,Graham W. Slack,King L. Tan,Fong Chun Chan,Raymond S. Lim,Joseph M. Connors,Marco A. Marra,Andrew J. Mungall,Christian Steidl,Randy D. Gascoyne
Myeloid Neoplasia
Phagocytes, Granulocytes, and Myelopoiesis
Platelets and Thrombopoiesis
Red Cells, Iron, and Erythropoiesis
Transplantation
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Peter Dreger,on behalf of the German CLL Study Group,Hartmut Döhner,on behalf of the German CLL Study Group,Fabienne McClanahan,on behalf of the German CLL Study Group,Raymonde Busch,on behalf of the German CLL Study Group,Matthias Ritgen,on behalf of the German CLL Study Group,Hildegard Greinix,on behalf of the German CLL Study Group,Anna-Maria Fink,on behalf of the German CLL Study Group,Wolfgang Knauf,on behalf of the German CLL Study Group,Michael Stadler,on behalf of the German CLL Study Group,Michael Pfreundschuh,on behalf of the German CLL Study Group,Ulrich Dührsen,on behalf of the German CLL Study Group,Günter Brittinger,on behalf of the German CLL Study Group,Manfred Hensel,on behalf of the German CLL Study Group,Johannes Schetelig,on behalf of the German CLL Study Group,Dirk Winkler,on behalf of the German CLL Study Group,Andreas Bühler,on behalf of the German CLL Study Group,Michael Kneba,on behalf of the German CLL Study Group,Norbert Schmitz,on behalf of the German CLL Study Group,Michael Hallek,on behalf of the German CLL Study Group,Stephan Stilgenbauer,on behalf of the German CLL Study Group
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Aristeidis Chaidos,Scott Patterson,Richard Szydlo,Mohammed Suhail Chaudhry,Francesco Dazzi,Edward Kanfer,Donald McDonald,David Marin,Dragana Milojkovic,Jiri Pavlu,John Davis,Amin Rahemtulla,Katy Rezvani,John Goldman,Irene Roberts,Jane Apperley,Anastasios Karadimitris
Vascular Biology
Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase
Benoit Detry,Charlotte Erpicum,Jenny Paupert,Silvia Blacher,Catherine Maillard,Françoise Bruyère,Hélène Pendeville,Thibault Remacle,Vincent Lambert,Cédric Balsat,Sandra Ormenese,Françoise Lamaye,Els Janssens,Lieve Moons,Didier Cataldo,Frédéric Kridelka,Peter Carmeliet,Marc Thiry,Jean-Michel Foidart,Ingrid Struman,Agnès Noel
Other Departments
-
Cover Image
Cover Image
Expression of a nuclear green fluorescent protein transgene within primitive erythroblasts (EryP) of the yolk sac “blood islands” of a day-8.5 mouse embryo. At this stage, before the initiation of a heartbeat and the onset of circulation, EryP progenitor activity is still present. The head of the embryo is visible at left, while the tail and enlarging allantois are visible at right. See the article by Baron et al on page 4828.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals